Document is current
Any future updates will be listed below
-
Authors
Tang, Chengyun
Border, Jane J.
Zhang, Huawei
Gregory, Andrew
Bai, Shan
Fang, Xing
Liu, Yedan
Wang, Shaoxun
Hwang, Sung Hee
Gao, Wenjun
Morgan, Gilbert C.
Smith, Jhania
Bunn, David
Cantwell, Cameron
Wagner, Karen M.
Morisseau, Christophe
Yang, Jun
Shin, Seung Min
O’Herron, Philip
Bagi, Zsolt
Filosa, Jessica A.
Dong, Yanbin
Yu, Hongwei
Hammock, Bruce D.
Roman, Richard J.
-
Funding
Funding for this research was provided by:
Foundation for the National Institutes of Health (AG079336, AG057842, P20GM104357, R35ES030443, U54NS127758, 5P42ES004699)
Augusta University (TRIBA Faculty Startup Fund)
Harrington Discovery Institute, University Hospitals (A25-1690)
American Heart Association (25PRE1365157)
- License Information
-
More Information
Article History
Received: 27 November 2024
Accepted: 27 January 2025
First Online: 4 February 2025
Declarations
:
: Not applicable.
: All participants have consented to the publication.
: B.D. Hammock is a founder and S.H. Hwang, and J. Yang are employees of EicOsis L.L.C., a startup company with an sEH inhibitor in human clinical trials.
